Article today in the Herald Sun about the Aust stocks under $5 and some tips by experts.
NATHAN BELL, PORTFOLIO MANAGER, INVESTSMART has MSB in his Top 5 Avoids with an average price of $1.87. Reason ?
Top tip: “The key things to look for in a potential high growth winner are a large potential market, which usually means being successful in the US. Preferably having management (the founder) with the bulk of their net worth invested in the company. The company doesn’t necessarily need to be profitable, but it has to have a clear path to profitability and the cash to invest to get there. Usually the company will need to have high market share, otherwise profits will always be under pressure from competitors.
And he still wants you to avoid MSB ?
Cell Therapy News/Articles, page-9635
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.40 |
Change
0.045(3.33%) |
Mkt cap ! $1.592B | |||
| Open | High | Low | Value | Volume |
| $1.35 | $1.42 | $1.33 | $3.802M | 2.753M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 23940 | $1.39 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.40 | 22571 | 2 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |